Chinese Demand For Immunity Supplements Drives Up Swisse's Sales
Executive Summary
Australian-heritage supplements brand Swisse capitalized on increased demand for immunity products during the COVID-19 pandemic to deliver sales growth of more than 25% in the first half of 2020.